122.19
+5.55%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Hinge Health
From its filings with the US Securities and Exchange Commission
Hinge Health is based in San Francisco, California and is incorporated in Delaware. Its shares trade on NYSE under the ticker HNGE. The SEC classifies its business as computer processing & data preparation. In the fiscal year to 31 December 2025, it reported revenue of $587.9m and a net loss of $528.3m. At that date it held total assets of $744.8m and shareholders' equity of $178.7m.
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care.
Hinge Health leverages software, including AI, to automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients and members. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Our platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life.
We have developed an efficient go-to-market model by working directly with our partners and clients. We seek to be the most validated and the easiest to buy solution on the market. Our clients are primarily self-insured employers and include many of the nation’s leading enterprises across a broad range of industries and sizes. Within this segment, we also serve many public sector self-insured employers, such as state and local city governments and labor unions.
Quoted from its 10-K, filed 3 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 22 May 2025
- Employees
- 1,437
- Website
- en-gb.hingehealth.com ↗
- Head office
- 455 MARKET STREET, SAN FRANCISCO, CA, 94105
- Incorporated in
- DE
- Classification
- Services-Computer Processing & Data Preparation
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. Gabriel MecklenburgExecutive Chairman of the Board, Co-Founder$501,828
- Mr. Jim PursleyPresident$2.8m
- Mr. Daniel PerezChief Executive Officer, Co-Founder, Director, since 2012$508,728
- Mr. James BudgeChief Financial Officer$3.1m
- Ms. Kristina LeslieIndependent Director$989,100
- Mr. Elliott RobinsonIndependent Director
- Mr. Teddie WardiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Headquartered in San Francisco, California with 1,437 employees.
- Offers a TrueMotion platform for musculoskeletal care from acute injury to chronic pain.
- Provides AI-powered motion tracking technology for personalized MSK care.
Weaknesses
- IPO date is listed as 2025-05-22, which is in the future.
- The source description mentions 1,514 employees, conflicting with the provided 1,437.
- Enso wearable device is described as offering electrical nerve stimulation, but no sales data is provided.
Opportunities
- The TrueMotion platform addresses a spectrum of musculoskeletal care needs.
- AI-supported care team includes licensed physical therapists and physicians.
- Enso device provides non-addictive pain relief as a non-invasive option.
Threats
- IPO date in the future may affect market perception and investor confidence.
- Conflicting employee count between source and provided data creates uncertainty.
- Lack of sales data for Enso device could hinder market adoption analysis.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.